Icon Advisers Inc. Co. Sells 4,916 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Icon Advisers Inc. Co. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 60.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,203 shares of the healthcare conglomerate's stock after selling 4,916 shares during the quarter. Icon Advisers Inc. Co.'s holdings in UnitedHealth Group were worth $1,620,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $25,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $28,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at $30,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group in the 4th quarter worth $30,000. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $32,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $3.63 during midday trading on Tuesday, hitting $583.43. 3,865,335 shares of the stock traded hands, compared to its average volume of 4,340,638. The firm has a market capitalization of $533.67 billion, a P/E ratio of 37.64, a PEG ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a one year low of $438.50 and a one year high of $630.73. The firm has a 50-day moving average of $513.80 and a two-hundred day moving average of $541.83.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $5.83 EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.33% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on UNH. Cantor Fitzgerald restated an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Piper Sandler reduced their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research note on Thursday, January 2nd. KeyCorp restated an "overweight" rating and set a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Finally, HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price for the company in a research note on Friday, January 10th. Twenty-one analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $632.85.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.